Jean Hailes, 2 September 2019
The first Global Position Statement on the use of testosterone in the treatment of women, led by the International Menopause Society (IMS), was published in four leading international medical journals today.
The statement has been authored by a diverse team of leading experts based around the world and has been endorsed by internationally-esteemed medical societies.
It follows years of debate regarding testosterone therapy for women and, for the first time, provides agreement among experts and medical societies about how testosterone could be prescribed for women.
Access the statement: